HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 15 and consisting of 11 or less amino acid residues.
1. A method for inducing an immune response in a subject suffering from cancer, comprising a step of administrating to the subject a peptide consisting of the amino acid sequence of SEQ ID NO: 7.
2. The method according to claim 1 , wherein the peptide can bind to one or more types of HLA molecules.
3. A method for inducing an immune response in a subject suffering from cancer, comprising a step of administrating to the subject a pharmaceutical composition comprising a peptide consisting of the amino acid sequence of SEQ ID NO: 7 and a pharmaceutically acceptable formulation component.
4. The method according to claim 3 , wherein the pharmaceutical composition is in the form of a vaccine.
5. The method according to claim 4 , wherein the peptide can bind to one or more types of HLA molecules.